Nothing Special   »   [go: up one dir, main page]

DK3166960T3 - Lav-substituerede polymyxiner og sammensætninger deraf - Google Patents

Lav-substituerede polymyxiner og sammensætninger deraf Download PDF

Info

Publication number
DK3166960T3
DK3166960T3 DK15735887.0T DK15735887T DK3166960T3 DK 3166960 T3 DK3166960 T3 DK 3166960T3 DK 15735887 T DK15735887 T DK 15735887T DK 3166960 T3 DK3166960 T3 DK 3166960T3
Authority
DK
Denmark
Prior art keywords
polymyxines
substituted
compositions
low
substituted polymyxines
Prior art date
Application number
DK15735887.0T
Other languages
English (en)
Inventor
Vidar Bjørnstad
Sølvi Gunnes
Torben Koch
Claes Melander
Original Assignee
Xellia Pharmaceuticals Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xellia Pharmaceuticals Aps filed Critical Xellia Pharmaceuticals Aps
Application granted granted Critical
Publication of DK3166960T3 publication Critical patent/DK3166960T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62Polymyxins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK15735887.0T 2014-07-09 2015-06-29 Lav-substituerede polymyxiner og sammensætninger deraf DK3166960T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462022399P 2014-07-09 2014-07-09
PCT/EP2015/064764 WO2016005223A1 (en) 2014-07-09 2015-06-29 Low substituted polymyxins and compositions thereof

Publications (1)

Publication Number Publication Date
DK3166960T3 true DK3166960T3 (da) 2019-10-14

Family

ID=53539668

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15735887.0T DK3166960T3 (da) 2014-07-09 2015-06-29 Lav-substituerede polymyxiner og sammensætninger deraf

Country Status (16)

Country Link
US (1) US10711040B2 (da)
EP (1) EP3166960B1 (da)
JP (1) JP2017523953A (da)
KR (1) KR20170032348A (da)
CN (1) CN106661090A (da)
AU (1) AU2015286956A1 (da)
BR (1) BR112017000228A2 (da)
CA (1) CA2949328C (da)
DK (1) DK3166960T3 (da)
EA (1) EA201692569A1 (da)
ES (1) ES2749053T3 (da)
HU (1) HUE046814T2 (da)
IL (1) IL249695A0 (da)
PT (1) PT3166960T (da)
SI (1) SI3166960T1 (da)
WO (1) WO2016005223A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10640536B2 (en) 2013-01-11 2020-05-05 Xellia Pharmaceuticals Aps Polymyxins, compositions, methods of making and methods of use
SI3200762T1 (sl) 2014-10-03 2019-08-30 Xellia Pharmaceuticals Aps Naprava za inhalacijo
JP6633061B2 (ja) 2014-10-03 2020-01-22 クセリア ファーマシューティカルズ エーピーエスXellia Pharmaceuticals ApS 組成物
CN110845579B (zh) * 2019-08-08 2022-04-19 上海市食品药品检验研究院 一种多黏菌素e组分及其光化学产物和液相色谱-质谱分析方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1062895A (en) 1962-12-13 1967-03-22 Wellcome Found Sulphomethyl derivatives of polymxin
DE1906699A1 (de) 1968-02-12 1970-02-05 Pfizer Neue Polymyxinderivate und Verfahren zu deren Herstellung
FR1586834A (da) 1968-02-12 1970-03-06
AU611030B2 (en) 1988-04-07 1991-05-30 Edward Shanbrom Non-thrombogenic intravascular time release catheter
CA2242335A1 (en) 1996-11-15 1998-05-22 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
US5767068A (en) * 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
DE60210402T2 (de) 2001-05-18 2006-12-07 Chiron Corp., Emeryville System zur Abgabe einer Tobramycin-Formulierung
US20040022740A1 (en) 2001-07-10 2004-02-05 Baker William R. Macrolide formulations for inhalation and methods of treatment of endobronchial infections
PT1340506E (pt) 2002-03-01 2007-03-30 Chiesi Farma Spa Composições que incluem surfactantes pulmonares e uma polimixina que melhoram as propriedades da superfície
WO2008025560A1 (en) 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
US20080066739A1 (en) 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
US9005990B2 (en) * 2009-10-30 2015-04-14 Xellia Pharmaceuticals Aps Method for purification of colistin and purified colistin components
WO2012168820A1 (en) 2011-06-08 2012-12-13 Pfizer Inc. Polymyxin derivatives useful as antibacterial agents
US10640536B2 (en) 2013-01-11 2020-05-05 Xellia Pharmaceuticals Aps Polymyxins, compositions, methods of making and methods of use
TW201522364A (zh) 2013-06-07 2015-06-16 Xellia Pharmaceuticals Aps 黏菌素甲磺酸鈉(cms)之定性方法
JP6633061B2 (ja) 2014-10-03 2020-01-22 クセリア ファーマシューティカルズ エーピーエスXellia Pharmaceuticals ApS 組成物

Also Published As

Publication number Publication date
PT3166960T (pt) 2019-10-25
EP3166960B1 (en) 2019-08-07
EA201692569A1 (ru) 2017-05-31
CA2949328C (en) 2023-01-31
HUE046814T2 (hu) 2020-03-30
US20170218024A1 (en) 2017-08-03
SI3166960T1 (sl) 2019-12-31
JP2017523953A (ja) 2017-08-24
ES2749053T3 (es) 2020-03-18
EP3166960A1 (en) 2017-05-17
WO2016005223A1 (en) 2016-01-14
BR112017000228A2 (pt) 2017-10-31
US10711040B2 (en) 2020-07-14
KR20170032348A (ko) 2017-03-22
AU2015286956A1 (en) 2016-12-08
IL249695A0 (en) 2017-02-28
CN106661090A (zh) 2017-05-10
CA2949328A1 (en) 2016-01-14

Similar Documents

Publication Publication Date Title
FIC20230014I1 (fi) Foslevodopa ja foskarbidopa
DK3495023T3 (da) Semifluorerede forbindelser og sammensætninger deraf
DK3210977T3 (da) Hidtil ukendt aminoalkylbenzothiazepinderivat og anvendelse deraf
DK3215147T3 (da) Neurodæmpende norketamin-forbindelser og fremgangsmåder
DK3234133T3 (da) Crispr-baserede sammensætninger og fremgangsmåder til anvendelse
DK3212255T3 (da) Selvorienterende sprøjte og sprøjtegrænseflade
DK3169741T3 (da) Forbedrede bindemiddelsammensætninger og anvendelser deraf
DK3218358T3 (da) Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner
DK3018183T3 (da) Halogenolefinbaseret sammensætning og anvendelse deraf
DK3316909T3 (da) Anti-ntb-a-antistoffer og relaterede sammensætninger og fremgangsmåder
KR20180084891A (ko) 구조 조성물 및 방법
DK3357513T3 (da) Farmaceutisk sammensætning og anvendelse deraf
DK3102200T3 (da) Terapeutisk forbindelse og sammensætning
DK3236991T3 (da) Fgf21-derivater og anvendelser deraf
DK3209773T3 (da) Prolintolerante tripeptidylpeptidaser og anvendelser deraf
DK3220750T3 (da) Oral rehydreringssammensætning og fremgangsmåder dertil
DK3194564T3 (da) Trichodermasammensætninger og anvendelsesfremgangsmåder
DK3161139T3 (da) Tlr-4-specifikke aptamerer og anvendelser heraf
DK3324932T3 (da) Sammensætninger og fremgangsmåder for nanopartikel lyofile former
DK3265641T3 (da) Stigørenhed og fremgangsmåde
DK3212776T3 (da) Sammensætninger og fremgangsmåder i forbindelse med beta-glucosidase
DK3128005T3 (da) Sirp-alfa-variantkonstruktioner og anvendelser deraf
DK3223796T3 (da) Farmaceutiske sammensætninger, fremstilling og anvendelser deraf
DK3231793T3 (da) Dihydropyromidin-2-on-forbindelser og medicinske anvendelser deraf
DK3365321T3 (da) Solabegron-zwitterion og anvendelser deraf